LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC (http://www.Goldberglawpc.com) announces that it is investigating claims of potential misrepresentations by Immunomedics, Inc. (“Immunomedics” or the “Company”) (NASDAQ: IMMU). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors. If you purchased or otherwise acquired Immunomedics shares and would like more information regarding the investigation, we advise you to